Impact of Pulmonary Arterial Hypertension on Left Ventricular Function – a Comparative Study between Scleroderma and Coronary Artery Disease

1. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D34-D41.10.1016/j.jacc.2013.10.02924355639Search in Google Scholar

2. Chaisson NF, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Chest. 2013;144:1346-1356.10.1378/chest.12-2396378792024081346Search in Google Scholar

3. Tedford R, Mudd J, Girgis R, et al. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circ Heart Fail. 2013;6:953-963.10.1161/CIRCHEARTFAILURE.112.000008381569723797369Search in Google Scholar

4. Nguyen C, Bérezné A, Baubet T, et al. Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis. PLoS One. 2011;6:e17551.10.1371/journal.pone.0017551305231921408076Search in Google Scholar

5. Le Pavec J, Humbert M, Mouthon L, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010;181:1285-1293.10.1164/rccm.200909-1331PP289440720194816Search in Google Scholar

6. Ryan JJ, Thenappan T, Luo N, et al. The WHO classification of pulmonary hypertension: A case-based imaging compendium. Pulm Circ. 2012;2:107-121.10.4103/2045-8932.94843334273922558526Search in Google Scholar

7. Ferri C, Giuggioli D, Sebastiani M, Colaci M, Emdin M. Heart involvement and systemic sclerosis. Lupus. 2005;14:702-707.10.1191/0961203305lu2204oa16218471Search in Google Scholar

8. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360:1989-2003.10.1056/NEJMra080618819420368Search in Google Scholar

9. Fernandes F, Ramires FJ, Arteaga E, et al. Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail. 2003;9:311-317.10.1054/jcaf.2003.5113680552Search in Google Scholar

10. Plazak W, Zabinska-Plazak E, Wojas-Pelc A, et al. Heart structure and function in systemic sclerosis. Eur J Dermatology. 2002;12:257-262.Search in Google Scholar

11. Lindqvist P, Caidahl K, Neuman-Andersen G, et al. Disturbed right ventricular diastolic function in patients with systemic sclerosis. A Doppler tissue imaging study. Chest. 2005;128:755-763.10.1378/chest.128.2.75516100164Search in Google Scholar

12. Durmus E, Sunbul M, Tigen K, et al. Right ventricular and atrial functions in systemic sclerosis patients without pulmonary hypertension: speckle-tracking echocardiographic study. Herz. 2014;40:709-715.10.1007/s00059-014-4113-2Search in Google Scholar

13. Hirooka K, Naito J, Koretsune Y, et al. Analysis of transmural trends in myocardial integrated backscatter in patients with progressive systemic sclerosis. J Am Soc Echocardiogr. 2003;16:340-346.10.1016/S0894-7317(02)74427-1Search in Google Scholar

14. D’Angelo WA, Fries JF, Masi AT, et al. Pathological observations in systemic sclerosis (scleroderma): A study of 58 autopsy cases and 58 matched controls. Am J Med. 1969;46:428-440.10.1016/0002-9343(69)90044-8Search in Google Scholar

15. Gaasch W, Zile M. Left Ventricular Diastolic Dysfunction and Diastolic Heart Failure. Annual Review of Medicine. 2004;55:373-394.10.1146/annurev.med.55.091902.104417Search in Google Scholar

16. Allman K, Shaw L, Hachamovitch R, Udelson J. Myocardial Viability Testing and Impact of Revascularization on Prognosis in Patients With Coronary Artery Disease and Left Ventricular Dysfunction: A Meta-Analysis. J Am Coll Cardiol. 2002;39:1151-1158.10.1016/S0735-1097(02)01726-6Search in Google Scholar

17. Beller GA. Noninvasive assessment of myocardial viability. N Engl J Med. 2000;343:1488-1490.10.1056/NEJM20001116343201111078777Search in Google Scholar

18. Bulkley BH, Ridolfi RL, Salyer WR, et al. Myocardial lesions of progressive systemic sclerosis, a cause of cardiac dysfunction. Circulation. 1976;53:483-490.10.1161/01.CIR.53.3.483Search in Google Scholar

19. Armstrong GP, Whalley GA, Doughty RN, et al. Left ventricular function in scleroderma. Br J Rheumatol. 1996;35:983-988.10.1093/rheumatology/35.10.9838883437Search in Google Scholar

20. Candell-Riera J, Armadans-Gil L, Simeon CP, et al. Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis. Arthritis Rheum. 1996;39:1138-1145.10.1002/art.17803907108670322Search in Google Scholar

21. Turiel M, Gianturco L, Ricci C, et al. Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross-sectional study. Arthritis Care Res (Hoboken). 2012;65:274-280.10.1002/acr.2181922899452Search in Google Scholar

22. Fernandes F, Ramires FJ, Arteaga E, Ianni BM, Bonfa ES, Mady C. Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail. 2003;9:311-317.10.1054/jcaf.2003.51Search in Google Scholar

23. Kahan A, Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology. 2006;45:iv14-iv17.10.1093/rheumatology/kel312Search in Google Scholar

24. Wang M, Yip GW, Wang AY, et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol. 2003;41:820-826.10.1016/S0735-1097(02)02921-2Search in Google Scholar

25. De Groote P, Gressin V, Hachulla E, et al. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis. 2008;67:31-36.10.1136/ard.2006.05776017267515Search in Google Scholar

26. Olivotti L, Cosmi D, Nicolino A, Martinelli L, Moshiri S, Danzi GB. Large Left Ventricular Aneurysm and Multifocal Myocardial Involvement in a Patient with Systemic Sclerosis. Can J Cardiol. 2017;33:950.e5-950.e6.10.1016/j.cjca.2017.03.01728668148Search in Google Scholar

27. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009;10:165-193.10.1093/ejechocard/jep00719270053Search in Google Scholar

28. Hinchcliff M, Desai CS, Varga J, Shah SJ. Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis. Clin Exp Rheumatol. 2012;30:S30-S37.Search in Google Scholar

29. Meune C, Vignaux O, Kahan A, Allanore Y. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Archives of Cardiovascular Diseases. 2010;103:46-52.10.1016/j.acvd.2009.06.00920142120Search in Google Scholar

30. Yiu KH, Schouffoer AA, Marsan NA. Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias. Arthritis Rheum. 2011;63:3969-3978.10.1002/art.3061422127711Search in Google Scholar

31. Meune C, Avouac J, Wahbi K, et al.Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis Rheum. 2008;58:1803-1809.10.1002/art.2346318512815Search in Google Scholar